Gri Bio Inc (GRI) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access GRI Annual Balance Sheets →
The balance sheet data below highlights changes in Gri Bio Inc's financial position over recent quarters.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent10.95
Cash & Short-term Investments10.00
Other Current Assets0.00
Prepaid Expense And Other Assets Current0.39
Total Current Assets11.33
Equipment/Property/Plant Net0.04
Other Assets, Noncurrent0.01
Operating Lease Right Of Use Asset0.06
Total Assets11.38
Liabilities
Accounts Payable, Current AC0.53
Accrued Liabilities, Current AC0.53
Other Liabilities, Current0.04
Total Current Liabilities1.10
Total Long-term Debt0.00
Other liabilities, Noncurrent0.00
OperatingLeaseLiabilityNoncurrent-
Operating Lease Liability Current0.06
Total Liabilities1.10
Stockholders' Equity
Additional Paid In Capital Common Stock65.62
Retained Earnings / Accumulated Deficit-55.34
Common Stockholder's Equity10.28
Total Stockholder's Equity10.28
Liabilities & Stockholder's Equity11.38
4 historic quarters locked

Sign in to unlock the full Gri Bio Inc balance sheet history.

About Gri Bio Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001824293-26-000055

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.